COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $187 | -38.1% | 43,992 | -0.5% | 0.00% | -50.0% |
| Q1 2023 | $302 | -15.2% | 44,203 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $356 | -99.9% | 44,952 | +0.4% | 0.00% | -33.3% |
| Q3 2022 | $430,000 | +22.5% | 44,759 | -7.8% | 0.01% | +50.0% |
| Q2 2022 | $351,000 | -38.6% | 48,546 | +9.5% | 0.00% | -33.3% |
| Q1 2022 | $572,000 | -20.6% | 44,336 | -1.8% | 0.01% | -14.3% |
| Q4 2021 | $720,000 | -3.2% | 45,126 | -2.5% | 0.01% | 0.0% |
| Q3 2021 | $744,000 | +16.8% | 46,306 | +0.5% | 0.01% | +16.7% |
| Q2 2021 | $637,000 | +0.6% | 46,097 | +6.3% | 0.01% | -14.3% |
| Q1 2021 | $633,000 | -26.1% | 43,359 | -12.1% | 0.01% | -30.0% |
| Q4 2020 | $857,000 | -20.6% | 49,349 | -16.1% | 0.01% | -23.1% |
| Q3 2020 | $1,079,000 | +5.1% | 58,840 | +2.3% | 0.01% | 0.0% |
| Q2 2020 | $1,027,000 | – | 57,530 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |